<SEC-DOCUMENT>0001654954-19-003213-index.html : 20190325
<SEC-HEADER>0001654954-19-003213.hdr.sgml : 20190325
<ACCEPTANCE-DATETIME>20190325141940
ACCESSION NUMBER:		0001654954-19-003213
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190325
DATE AS OF CHANGE:		20190325

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89486
		FILM NUMBER:		19702244

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Caribou Biosciences, Inc.
		CENTRAL INDEX KEY:			0001619856
		IRS NUMBER:				453728228
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		2929 7TH STREET, SUITE 105
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		510-982-6030

	MAIL ADDRESS:	
		STREET 1:		2929 7TH STREET, SUITE 105
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>sch13ga_am3feb2019.htm
<DESCRIPTION>AMENDMENT NO. 3
<TEXT>
Document 1 - file: sch13ga_am3feb2019.htm

</DOCUMENT>
</SEC-DOCUMENT>